Achieve Life SCIENCES, Inc. (ACHV) intrinsic value & 10-year financials
Achieve Life SCIENCES, Inc. (ACHV) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $6.38
- Market cap
- $278.1M
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- -116.1%
- Free cash flow (FY2025)
- -$49.5M
ACHV 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$54.6M | -$1.25 | -$49.5M | — | -1241.2% |
| FY2024 | — | -$39.8M | -$1.24 | — | — | 907.6% |
| FY2023 | — | -$29.8M | -$1.50 | -$24.5M | — | 178.6% |
| FY2022 | — | -$42.4M | -$4.00 | — | — | 270.0% |
| FY2021 | — | -$33.2M | -$4.08 | — | — | 492.4% |
| FY2020 | — | -$14.7M | -$1.81 | -$13.5M | — | -964.3% |
| FY2019 | $0 | -$16.4M | — | -$15.3M | — | -418.0% |
| FY2018 | $0 | -$12.7M | — | -$10.7M | — | -201.4% |
| FY2017 | — | -$10.6M | — | — | — | -78.8% |
| FY2016 | $5.1M | -$20.1M | — | -$248.0K | — | -106.1% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
ACHIEVE LIFE SCIENCES, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
ACHIEVE LIFE SCIENCES, INC. has historically struggled to out-earn its cost of capital, averaging just -19.5% ROIC.
ACHIEVE LIFE SCIENCES, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
ACHIEVE LIFE SCIENCES, INC. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.